ACCEDO CARE LTD
Opportunity 78/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Cash flow review and working-capital discipline. Cash down -68% YoY — forensic review of receivables, stock turns, and creditor days. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: medium (71/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · accounting standard not declaredKey financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | £1.78M | £1.87M |
| Current assets | £1.10M | £837.4k |
| Cash | £211.4k | £670.2k |
| Debtors | £885.3k | £167.2k |
| Net assets | £644.5k | £725.4k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 confirmation-statement
- • 1 accounts
Corporate timeline (25 events)Click to expand
- 2025-12-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-07-22📄termination-director-company-with-name-termination-dateofficers · TM01
- 2025-07-21➖COLLARD, Christopher Stanley resigneddirector
- 2025-02-04📄second-filing-of-confirmation-statement-with-made-up-dateconfirmation-statement · RP04CS01
- 2025-02-01📄change-person-director-company-with-change-dateofficers · CH01
- 2025-02-01📄change-person-director-company-with-change-dateofficers · CH01
- 2024-12-22📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-12-02📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-12-29📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-11-25📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-12-19📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-12-07📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2018-08-16📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2017-08-18📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2015-05-31➖SIDERAS, Louis Renos resigneddirector
- 2015-05-01➕COLLARD, Christopher Stanley appointeddirector
- 2014-05-31➖HAYNES, Carol resigneddirector
- 2013-12-29➕CONSTANTINOU, Eleni Margaret appointeddirector
- 2013-12-29➕GEORGIOU, Ruth appointeddirector
- 2013-12-29➕HAYNES, Carol appointeddirector
- 2013-08-23➕SIDERAS, Louis George, Mr. appointeddirector
- 2013-08-23➖ANTONIOU, Nicholas resigneddirector
- 2013-08-23➕SIDERAS, Louis Renos appointeddirector
- 2013-01-02🏢Company incorporatedAs ACCEDO CARE LTD
- 2013-01-02➕ANTONIOU, Nicholas appointeddirector
Owner dependency
Some founder dependency, but not acute. A structured handover period should cover most risk.
- +Senior director age: Director aged approximately 61 — approaching natural succession window.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- secondaryFounder aged 58+: Senior director is approximately 61. Early succession window.
- secondary12+ year tenure: Director in role 13 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanRadial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · N postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AARON UPPAL LTD→ 16386241 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| ABGLAUCOMA LTD→ 14521572 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| ABR PHARMA 94 LTD→ 15232143 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ABSOLUTELY EXQUISITE LIMITED→ 08111271 · est 2012 · no financials extracted | — | — | — | — | 13y | — | — |
| ACADEMY OF BLOOD CHEMISTRY LTD→ 16403087 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ACARINDA CARE LIMITED→ 16528253 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ACCARDI SMILE LIMITED→ 07312067 · est 2010 · no financials extracted | — | — | — | — | 15y | — | — |
| ACCORD VENTURE LIMITED→ 11432212 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ACCUHEART LTD→ 12116868 · est 2019 · no financials extracted | — | — | — | — | 6y | — | — |
| ACE PONDERSEND COMMUNITY INTEREST COMPANY→ 13620913 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| ACHIEVE PHYSIOTHERAPY LTD→ 09737878 · est 2015 · no financials extracted | — | — | — | — | 10y | — | — |
| ACHIEVEMED LTD→ 10455818 · est 2016 · no financials extracted | — | — | — | — | 9y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (3 active · 4 resigned)
Click a director name to see their full track record across all companies.